A double blind placebo control Trial to compare the safety and efficacy of Vitamin K2-7 (MK-7) in patients with peripheral neuropathy due to type 2 diabetes mellitus and/ or vitamin B12 deficiency

Synergia Life Sciences Pvt Ltd0 个研究点目标入组 60 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1.Male and female aged 18 to 65 who are suffering from type 2 diabetes mellitus and/ or vitamin B12 deficiency.
•2.Symptomatic diagnosis of neuropathy ( >4 on VAS score).
•3.Willing to give informed consent.

•1.Patients who are suffering from any other systemic illness other than type 2 diabetes mellitus or vitamin B12 deficiency.
•2.Patients who are on corticosteroids and oral contraceptives.
•3.Patients with seropositive status.
•4.Pregnancy.
•5.Patients Participation in clinical trials evaluating investigational pharmaceuticals or biologics within 3 months or devices within 30 days of admission to the study.
•6.Patients who are on coumarin analogues.
•7.Patients who are on Quinine Hydrochloride.
•8.History of alcohol. substance abuse or alcoholism, within the previous one year.

发起方